|
In vivo sensors using cerium nanoparticles
New electrode reduces material cost and extends operational life of glucose monitoring sensors Background The global market for electrode-based blood glucose test strips is $5 billion a year and steadily growing.1 Competition in this market is fierce, especially with the introduction of generic test strips and commodity pricing. Most commercially available...
|
|
Diagnosis of lung cancer subtypes using rapid molecular test
New cancer subtyping system can improve treatment options without disrupting clinical workflow.Problem Lung cancer is the leading cause of cancer death, with over 100,000 people dying per year.1 As most tumors are inoperable by the time the cancer is detected, patients are increasingly being placed on tailored treatment regimens. Prescribing targeted...
|
|
Postpartum intrauterine contraceptive device
Accessible, safe, and reversible IUD for better women’s health careProblem statementAbout 50% of U.S. pregnancies are unintended (UP) and can cost the U.S. government up to $21B yearly. UP within two years of a previous childbirth can lead to enhanced risk of adverse maternal and fetal outcomes. They can also indirectly impact education and career...
|
|
Fibrosis-free microfluidic meshwork implant for treating glaucoma
BackgroundGlaucoma is the leading cause of irreversible blindness in the world and affects almost three million people in the United States alone. The primary treatment option is to reduce the intraocular pressure (IOP) caused by fluid buildup in the affected eye, which is frequently accomplished by surgery to create an outflow of the accumulated fluid....
|
